4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001586785-26-000004
Chief Executive Officer gave up 21,892 shares (to pay taxes)
- Chief Executive Officer acquired 64,866 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NEIL GARRY ARTHUR Chief Executive Officer | 2026-03-28 | Option exercise | +64,866 | 112,006 | D: show line 1 in the form | ||
| NEIL GARRY ARTHUR Chief Executive Officer | 2026-03-28 | Shares withheld for taxes | −21,892 | $13.89 | $304,080 | 90,114 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| NEIL GARRY ARTHUR Chief Executive Officer | 2026-03-28 | Option exercise · Restricted Stock Units | −64,866 | 64,867 | D: show line 3 in the form |
Loading xslF345X06/form4-03312026_080315.xml…